Achema middle east

CPhI China & P-MEC China Post Show Report 2019

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Smart Laboratories and the Rise of Connected Pharma Equipment Ecosystems

Connected equipment ecosystems revolutionize pharmaceutical operations by integrating AI-driven analytics, digital twins, and seamless middleware to enhance visibility, collaboration, and decision-making across the value chain.

Maximizing Portfolio Returns During Late-Stage Drug Development

Optimize late-stage pharmaceutical assets through strategic investment planning, risk management, and indication prioritization. Maximize R&D return on investment during the highest-stakes phase of drug development.
- Advertisement -

CPhI & P-MEC China has become Asia’s largest and most specialised pharmaceutical event. Throughout the years, the event has witnessed the country’s pharmaceutical industry progress from playing catchup with the rest of the world to leading the way. 2019’s edition saw new records set in terms of scale as well as the number of exhibitors and visitors at the event.

This year’s exhibition area exceeded 200,000m2 – covering all 17 halls of the SNIEC – while exhibitor numbers reached 3,246 and the total visit number from both domestic and overseas visitors reached 66,569 – a 10% increase on 2018’s figures. The event also saw a 32% increase in overseas visits reaching 20,302. There was an endless stream of both Chinese and international traders going to stands onsite to negotiate, contributing to an unprecedentedly grand occasion

Click here to view the complete Post Report for CPhI China & P-MEC China

Latest stories

Related stories

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Smart Laboratories and the Rise of Connected Pharma Equipment Ecosystems

Connected equipment ecosystems revolutionize pharmaceutical operations by integrating AI-driven analytics, digital twins, and seamless middleware to enhance visibility, collaboration, and decision-making across the value chain.

Maximizing Portfolio Returns During Late-Stage Drug Development

Optimize late-stage pharmaceutical assets through strategic investment planning, risk management, and indication prioritization. Maximize R&D return on investment during the highest-stakes phase of drug development.

India Outpaces Global Average With 2026 Medical Trend at 11.5 Percent: Aon Reports

Cardiovascular diseases, gastrointestinal conditions and cancer are top medical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »